Navistar
Total Payments
$760,234
Transactions
543
Doctors
110
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $9,293 | 9 | 6 |
| 2023 | $36,799 | 17 | 14 |
| 2022 | $18,315 | 46 | 7 |
| 2021 | $4,169 | 9 | 2 |
| 2020 | $2,144 | 7 | 2 |
| 2019 | $259,979 | 25 | 12 |
| 2018 | $121,626 | 172 | 37 |
| 2017 | $307,910 | 258 | 61 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $650,241 | 89 | 85.5% |
| Travel and Lodging | $83,433 | 90 | 11.0% |
| Food and Beverage | $10,309 | 361 | 1.4% |
| Consulting Fee | $9,268 | 2 | 1.2% |
| Gift | $6,984 | 1 | 0.9% |
Payments by Type
Research
$650,241
89 transactions
General
$109,994
454 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Electrogram-Guided Myocardial Advanced Phenotyping (The eMAP Trial) | Medical Device Business Services, Inc. | $329,410 | 0 |
| NAVISTAR THERMOCOOL Catheter for the Radiofrequency Ablation of Drug Refractory Recurrent Symptomatic Paroxysmal Atrial Fibrillation-Post Approval Registry, PMA - AF Registry | Medical Device Business Services, Inc. | $232,096 | 0 |
| Cardiac positron emission tomography for detection of cardiac sympathetic dysinnervation to guide ablation of ventricular tachycardia (PET VT Study) | Biosense Webster, Inc. | $35,864 | 0 |
| NAVISTAR THERMOCOOL Catheter for the Radiofrequency Ablation of Drug Refractory Recurrent Symptomatic Paroxysmal Atrial Fibrillation - Post Approval Registry | Medical Device Business Services, Inc. | $27,090 | 0 |
| Navistar Thermocool Catheter for the Radiofrequency Ablation of Drug Refractory Recurrent Symptomatic Paroxysmal Atrial Fibrillation-Post Approval Registry, PMA - AF Registry | Medical Device Business Services, Inc. | $13,318 | 0 |
| Standard Ablation v. MRI-guided Ablation in the Treatment of Ventricular Tachycardia | Medical Device Business Services, Inc. | $7,000 | 0 |
| NAVISTAR THERMOCOOL Catheter for the Radiofrequency Ablation of Drug Refractory Recurrent Symptomatic Paroxysmal Atrial Fibrillation Post Approval Registry | Medical Device Business Services, Inc. | $3,400 | 0 |
| NAVISTAR THERMOCOOL Catheter for the Radiofrequency Ablation of Drug Refractory Recurrent Symptomatic Paroxysmal Atrial Fibrillation Post Approval Registry | Medical Device Business Services, Inc. | $2,063 | 0 |
Top Doctors Receiving Payments for Navistar
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Philadelphia, PA | $657,225 | 90 |
| , M.D | Clinical Cardiac Electrophysiology | Boston, MA | $16,141 | 7 |
| , M.D | Student in an Organized Health Care Education/Training Program | Detroit, MI | $16,019 | 6 |
| , M.D | Cardiovascular Disease | Murray, UT | $15,481 | 26 |
| , MD, PHD | Cardiovascular Disease | Bronx, NY | $9,377 | 7 |
| , MD | Internal Medicine | Boston, MA | $9,029 | 2 |
| , M.D | Internal Medicine | Salt Lake City, UT | $7,699 | 3 |
| , MD | Cardiovascular Disease | Austin, TX | $7,534 | 17 |
| , M.D | Cardiovascular Disease | Santa Monica, CA | $4,622 | 21 |
| , M.D | Cardiovascular Disease | Lexington, KY | $2,670 | 8 |
| , M.D | Cardiovascular Disease | Tupelo, MS | $1,572 | 3 |
| , M.D | Cardiovascular Disease | Austin, TX | $1,188 | 5 |
| , M.D | Clinical Cardiac Electrophysiology | Parlin, NJ | $710.55 | 26 |
| , MD | Internal Medicine | Elk Grove Village, IL | $686.40 | 2 |
| , M.D | Internal Medicine | Chicago, IL | $507.45 | 1 |
| , M.D | Internal Medicine | San Francisco, CA | $495.25 | 2 |
| , M.D | Cardiovascular Disease | Morristown, NJ | $489.75 | 44 |
| , MD | Clinical Cardiac Electrophysiology | Morristown, NJ | $470.24 | 38 |
| , MD | Clinical Cardiac Electrophysiology | Los Angeles, CA | $421.00 | 2 |
| , MD | Clinical Cardiac Electrophysiology | Morristown, NJ | $413.16 | 33 |
| , M.D | Clinical Cardiac Electrophysiology | Morristown, NJ | $406.94 | 33 |
| , MD | Clinical Cardiac Electrophysiology | Cleveland, OH | $389.15 | 3 |
| , MD | Clinical Cardiac Electrophysiology | Morristown, NJ | $372.06 | 47 |
| , M.D | Clinical Cardiac Electrophysiology | Murray, UT | $364.03 | 2 |
| , MD | Cardiovascular Disease | Oakland, CA | $308.60 | 1 |
Ad
Manufacturing Companies
- Medical Device Business Services, Inc. $614,622
- Biosense Webster, Inc. $145,613
Product Information
- Type Device
- Total Payments $760,234
- Total Doctors 110
- Transactions 543
About Navistar
Navistar is a device associated with $760,234 in payments to 110 healthcare providers, recorded across 543 transactions in the CMS Open Payments database. The primary manufacturer is Medical Device Business Services, Inc..
Payment data is available from 2017 to 2024. In 2024, $9,293 was paid across 9 transactions to 6 doctors.
The most common payment nature for Navistar is "Unspecified" ($650,241, 85.5% of total).
Navistar is associated with 8 research studies, including "Electrogram-Guided Myocardial Advanced Phenotyping (The eMAP Trial)" ($329,410).